Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Briviact (brivaracetam) For the Treatment of Partial Onset Seizures

Drug (Brand / Generic)

Briviact (brivaracetam)

Developer

UCB Pharma

Product Description

Synaptic vesicle protein 2A ligand

Current Indication

Epileptic seizures

Market Sector

CNS

Development Status

Approved in the US and Europe
Expand

Go Top